Sophia Analysis by Chemotherapy (Ctx) Choice: A Phase Iii (P3) Study of Margetuximab (M) plus Ctx Versus Trastuzumab (T) plus Ctx in Patients (Pts) with Pretreated Her2+Metastatic (Met) Breast Cancer (Mbc).

AuthID
P-00S-VCD
20
Author(s)
Escriva, S
·
Im, SA
·
Cardoso, F
·
Cortes, J
·
Curigliano, G
·
Pegram, MD
·
Levy, C
·
De laurentiis, M
·
Ferrero, JM
·
Bahadur, SW
·
Kim, SB
·
Petrakova, K
·
Riseberg, DA
·
Yardley, DA
·
Edlich, S
·
Hong, S
·
Rock, EP
·
Document Type
Abstract
Year published
2020
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 38, Issue: 15
Indexing
Publication Identifiers
Wos: WOS:000560368300210
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.